Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.

Stereoselective Analysis of Methadone and EDDP in Laboring Women and Neonates in Plasma and Dried Blood Spots and Association with Neonatal Abstinence Syndrome.

Metzger IF, Thomas AE, Evrard CA, Jones DR, Masters AR, Haas DM, Haneline LS, Quinney SK.

Am J Perinatol. 2020 Feb 12. doi: 10.1055/s-0040-1701505. [Epub ahead of print]

PMID:
32052397
2.

Effects of Pregnancy on the Pharmacokinetics of Metformin.

Liao MZ, Flood Nichols SK, Ahmed M, Clark S, Hankins GD, Caritis S, Venkataramanan R, Haas D, Quinney SK, Haneline LS, Tita AT, Manuck T, Wang J, Thummel KE, Brown LM, Ren Z, Easterling TR, Hebert MF.

Drug Metab Dispos. 2020 Apr;48(4):264-271. doi: 10.1124/dmd.119.088435. Epub 2020 Jan 24.

PMID:
31980499
3.

Improving natural product research translation: From source to clinical trial.

Sorkin BC, Kuszak AJ, Bloss G, Fukagawa NK, Hoffman FA, Jafari M, Barrett B, Brown PN, Bushman FD, Casper SJ, Chilton FH, Coffey CS, Ferruzzi MG, Hopp DC, Kiely M, Lakens D, MacMillan JB, Meltzer DO, Pahor M, Paul J, Pritchett-Corning K, Quinney SK, Rehermann B, Setchell KDR, Sipes NS, Stephens JM, Taylor DL, Tiriac H, Walters MA, Xi D, Zappalá G, Pauli GF.

FASEB J. 2020 Jan;34(1):41-65. doi: 10.1096/fj.201902143R. Epub 2019 Dec 10.

PMID:
31914647
4.

Pharmacodynamics of Glyburide, Metformin, and Glyburide/Metformin Combination Therapy in the Treatment of Gestational Diabetes Mellitus.

Shuster DL, Shireman LM, Ma X, Shen DD, Flood Nichols SK, Ahmed MS, Clark S, Caritis S, Venkataramanan R, Haas DM, Quinney SK, Haneline LS, Tita AT, Manuck TA, Thummel KE, Brown LM, Ren Z, Brown Z, Easterling TR, Hebert MF.

Clin Pharmacol Ther. 2019 Dec 23. doi: 10.1002/cpt.1749. [Epub ahead of print]

PMID:
31869430
5.

Translational Knowledge Discovery Between Drug Interactions and Pharmacogenetics.

Wu HY, Shendre A, Zhang S, Zhang P, Wang L, Zeruesenay D, Rocha LM, Shatkay H, Quinney SK, Ning X, Li L.

Clin Pharmacol Ther. 2020 Apr;107(4):886-902. doi: 10.1002/cpt.1745. Epub 2020 Feb 3.

PMID:
31863452
6.

Pharmacodynamics of Metformin in Pregnant Women With Gestational Diabetes Mellitus and Nonpregnant Women With Type 2 Diabetes Mellitus.

Shuster DL, Shireman LM, Ma X, Shen DD, Flood Nichols SK, Ahmed MS, Clark S, Caritis S, Venkataramanan R, Haas DM, Quinney SK, Haneline LS, Tita AT, Manuck TA, Thummel KE, Morris Brown L, Ren Z, Brown Z, Easterling TR, Hebert MF.

J Clin Pharmacol. 2020 Apr;60(4):540-549. doi: 10.1002/jcph.1549. Epub 2019 Nov 19.

PMID:
31742716
7.

The Impact of Hepatitis C Virus Infection on Buprenorphine Dose in Pregnancy.

McDowell ML, Tonismae TR, Slaven JE, Abernathy MP, Shanks AL, Benjamin TD, Quinney SK.

Am J Perinatol. 2020 Jan;37(1):73-78. doi: 10.1055/s-0039-1698838. Epub 2019 Oct 26.

PMID:
31655490
8.

The Cancer Drug Fraction of Metabolism Database.

Hua L, Chiang CW, Cong W, Li J, Wang X, Cheng L, Feng W, Quinney SK, Wang L, Li L.

CPT Pharmacometrics Syst Pharmacol. 2019 Jul;8(7):511-519. doi: 10.1002/psp4.12417. Epub 2019 Jun 17.

9.

Opportunities and Challenges of Using Big Data to Detect Drug-Drug Interaction Risk.

Quinney SK.

Clin Pharmacol Ther. 2019 Jul;106(1):72-74. doi: 10.1002/cpt.1481. Epub 2019 Jun 11. No abstract available.

10.

Controversies in antenatal corticosteroids.

Shanks AL, Grasch JL, Quinney SK, Haas DM.

Semin Fetal Neonatal Med. 2019 Jun;24(3):182-188. doi: 10.1016/j.siny.2019.05.002. Epub 2019 May 29.

PMID:
31155465
11.

A comparison of vaginal versus buccal misoprostol for cervical ripening in women for labor induction at term (the IMPROVE trial): a triple-masked randomized controlled trial.

Haas DM, Daggy J, Flannery KM, Dorr ML, Bonsack C, Bhamidipalli SS, Pierson RC, Lathrop A, Towns R, Ngo N, Head A, Morgan S, Quinney SK.

Am J Obstet Gynecol. 2019 Sep;221(3):259.e1-259.e16. doi: 10.1016/j.ajog.2019.04.037. Epub 2019 May 7.

PMID:
31075246
12.

Buccal versus Vaginal Misoprostol for Term Induction of Labor: A Retrospective Cohort Study.

Dorr ML, Pierson RC, Daggy J, Quinney SK, Haas DM.

Am J Perinatol. 2019 Jun;36(7):765-772. doi: 10.1055/s-0038-1675219. Epub 2018 Oct 31.

PMID:
30380580
13.

Mining Directional Drug Interaction Effects on Myopathy Using the FAERS Database.

Chasioti D, Yao X, Zhang P, Lerner S, Quinney SK, Ning X, Li L, Shen L.

IEEE J Biomed Health Inform. 2019 Sep;23(5):2156-2163. doi: 10.1109/JBHI.2018.2874533. Epub 2018 Oct 8.

PMID:
30296244
14.

Three-Component Mixture Model-Based Adverse Drug Event Signal Detection for the Adverse Event Reporting System.

Zhang P, Li M, Chiang CW, Wang L, Xiang Y, Cheng L, Feng W, Schleyer TK, Quinney SK, Wu HY, Zeng D, Li L.

CPT Pharmacometrics Syst Pharmacol. 2018 Aug;7(8):499-506. doi: 10.1002/psp4.12294. Epub 2018 Aug 9.

15.

DrugMetab: An Integrated Machine Learning and Lexicon Mapping Named Entity Recognition Method for Drug Metabolite.

Wu HY, Lu D, Hyder M, Zhang S, Quinney SK, Desta Z, Li L.

CPT Pharmacometrics Syst Pharmacol. 2018 Nov;7(11):709-717. doi: 10.1002/psp4.12340. Epub 2018 Sep 29.

16.

Translational Systems Pharmacology Studies in Pregnant Women.

Quinney SK, Gullapelli R, Haas DM.

CPT Pharmacometrics Syst Pharmacol. 2018 Feb;7(2):69-81. doi: 10.1002/psp4.12269. Epub 2017 Dec 14. Review.

17.

Translational Biomedical Informatics and Pharmacometrics Approaches in the Drug Interactions Research.

Zhang P, Wu HY, Chiang CW, Wang L, Binkheder S, Wang X, Zeng D, Quinney SK, Li L.

CPT Pharmacometrics Syst Pharmacol. 2018 Feb;7(2):90-102. doi: 10.1002/psp4.12267. Epub 2018 Jan 9. Review.

18.

Mixture drug-count response model for the high-dimensional drug combinatory effect on myopathy.

Wang X, Zhang P, Chiang CW, Wu H, Shen L, Ning X, Zeng D, Wang L, Quinney SK, Feng W, Li L.

Stat Med. 2018 Feb 20;37(4):673-686. doi: 10.1002/sim.7545. Epub 2017 Nov 23.

19.

Translational High-Dimensional Drug Interaction Discovery and Validation Using Health Record Databases and Pharmacokinetics Models.

Chiang CW, Zhang P, Wang X, Wang L, Zhang S, Ning X, Shen L, Quinney SK, Li L.

Clin Pharmacol Ther. 2018 Feb;103(2):287-295. doi: 10.1002/cpt.914. Epub 2017 Dec 11.

PMID:
29052226
20.

Characterization of Maternal and Fetal CYP3A-Mediated Progesterone Metabolism.

Quinney SK, Benjamin T, Zheng X, Patil AS.

Fetal Pediatr Pathol. 2017 Oct;36(5):400-411. doi: 10.1080/15513815.2017.1354411. Epub 2017 Sep 26.

21.

Survey of Provider Preferences Regarding the Route of Misoprostol for Induction of Labor at Term.

Towns R, Quinney SK, Pierson RC, Haas DM.

AJP Rep. 2017 Jul;7(3):e158-e162. doi: 10.1055/s-0037-1603954. Epub 2017 Jul 25.

22.

Effect of Gastric Fluid Volume on the In Vitro Dissolution and In Vivo Absorption of BCS Class II Drugs: a Case Study with Nifedipine.

Nader AM, Quinney SK, Fadda HM, Foster DR.

AAPS J. 2016 Jul;18(4):981-8. doi: 10.1208/s12248-016-9918-x. Epub 2016 Apr 22.

23.

How to Choose In Vitro Systems to Predict In Vivo Drug Clearance: A System Pharmacology Perspective.

Wang L, Chiang C, Liang H, Wu H, Feng W, Quinney SK, Li J, Li L.

Biomed Res Int. 2015;2015:857327. doi: 10.1155/2015/857327. Epub 2015 Oct 11.

24.

Graphic Mining of High-Order Drug Interactions and Their Directional Effects on Myopathy Using Electronic Medical Records.

Du L, Chakraborty A, Chiang CW, Cheng L, Quinney SK, Wu H, Zhang P, Li L, Shen L.

CPT Pharmacometrics Syst Pharmacol. 2015 Aug;4(8):481-8. doi: 10.1002/psp4.59. Epub 2015 Jul 6.

25.

A Mixture Dose-Response Model for Identifying High-Dimensional Drug Interaction Effects on Myopathy Using Electronic Medical Record Databases.

Zhang P, Du L, Wang L, Liu M, Cheng L, Chiang CW, Wu HY, Quinney SK, Shen L, Li L.

CPT Pharmacometrics Syst Pharmacol. 2015 Aug;4(8):474-80. doi: 10.1002/psp4.53. Epub 2015 Jul 6.

26.

Identification and Mechanistic Investigation of Drug-Drug Interactions Associated With Myopathy: A Translational Approach.

Han X, Quinney SK, Wang Z, Zhang P, Duke J, Desta Z, Elmendorf JS, Flockhart DA, Li L.

Clin Pharmacol Ther. 2015 Sep;98(3):321-7. doi: 10.1002/cpt.150.

27.

Fetal hyperglycemia and a high-fat diet contribute to aberrant glucose tolerance and hematopoiesis in adult rats.

Blue EK, Ballman K, Boyle F, Oh E, Kono T, Quinney SK, Thurmond DC, Evans-Molina C, Haneline LS.

Pediatr Res. 2015 Feb;77(2):316-25. doi: 10.1038/pr.2014.185. Epub 2014 Nov 20.

28.

Is personalized medicine achievable in obstetrics?

Quinney SK, Patil AS, Flockhart DA.

Semin Perinatol. 2014 Dec;38(8):534-40. doi: 10.1053/j.semperi.2014.08.017. Epub 2014 Oct 3. Review.

29.

Short-term tocolytics for preterm delivery - current perspectives.

Haas DM, Benjamin T, Sawyer R, Quinney SK.

Int J Womens Health. 2014 Mar 27;6:343-9. doi: 10.2147/IJWH.S44048. eCollection 2014. Review.

30.

Pharmacoepidemiologic and in vitro evaluation of potential drug-drug interactions of sulfonylureas with fibrates and statins.

Schelleman H, Han X, Brensinger CM, Quinney SK, Bilker WB, Flockhart DA, Li L, Hennessy S.

Br J Clin Pharmacol. 2014 Sep;78(3):639-48. doi: 10.1111/bcp.12353.

31.

Integration of in vitro binding mechanism into the semiphysiologically based pharmacokinetic interaction model between ketoconazole and midazolam.

Quinney SK, Knopp S, Chang C, Hall SD, Li L.

CPT Pharmacometrics Syst Pharmacol. 2013 Sep 11;2:e75. doi: 10.1038/psp.2013.50.

32.

Influence of dietary protein on glomerular filtration before and after bariatric surgery: a cohort study.

Friedman AN, Quinney SK, Inman M, Mattar SG, Shihabi Z, Moe S.

Am J Kidney Dis. 2014 Apr;63(4):598-603. doi: 10.1053/j.ajkd.2013.11.012. Epub 2013 Dec 31.

33.

Predicting the glomerular filtration rate in bariatric surgery patients.

Friedman AN, Moe S, Fadel WF, Inman M, Mattar SG, Shihabi Z, Quinney SK.

Am J Nephrol. 2014;39(1):8-15. doi: 10.1159/000357231. Epub 2013 Dec 19.

34.

Gestational diabetes induces alterations in the function of neonatal endothelial colony-forming cells.

Blue EK, DiGiuseppe R, Derr-Yellin E, Acosta JC, Pay SL, Hanenberg H, Schellinger MM, Quinney SK, Mund JA, Case J, Haneline LS.

Pediatr Res. 2014 Feb;75(2):266-72. doi: 10.1038/pr.2013.224. Epub 2013 Nov 14.

35.

CYP2B6 pharmacogenetics-based in vitro-in vivo extrapolation of efavirenz clearance by physiologically based pharmacokinetic modeling.

Xu C, Quinney SK, Guo Y, Hall SD, Li L, Desta Z.

Drug Metab Dispos. 2013 Dec;41(12):2004-11. doi: 10.1124/dmd.113.051755. Epub 2013 Jul 11.

36.

An integrated pharmacokinetics ontology and corpus for text mining.

Wu HY, Karnik S, Subhadarshini A, Wang Z, Philips S, Han X, Chiang C, Liu L, Boustani M, Rocha LM, Quinney SK, Flockhart D, Li L.

BMC Bioinformatics. 2013 Feb 1;14:35. doi: 10.1186/1471-2105-14-35.

37.

Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions.

Duke JD, Han X, Wang Z, Subhadarshini A, Karnik SD, Li X, Hall SD, Jin Y, Callaghan JT, Overhage MJ, Flockhart DA, Strother RM, Quinney SK, Li L.

PLoS Comput Biol. 2012;8(8):e1002614. doi: 10.1371/journal.pcbi.1002614. Epub 2012 Aug 9.

38.

Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolytic.

Haas DM, Quinney SK, Clay JM, Renbarger JL, Hebert MF, Clark S, Umans JG, Caritis SN; Obstetric-Fetal Pharmacology Research Units Network.

Am J Perinatol. 2013 Apr;30(4):275-81. doi: 10.1055/s-0032-1323590. Epub 2012 Aug 8.

39.

Rate of onset of inhibition of gut-wall and hepatic CYP3A by clarithromycin.

Quinney SK, Malireddy SR, Vuppalanchi R, Hamman MA, Chalasani N, Gorski JC, Hall SD.

Eur J Clin Pharmacol. 2013 Mar;69(3):439-48. doi: 10.1007/s00228-012-1339-x. Epub 2012 Jul 10.

40.

A Semi-Mechanistic Metabolism Model of CYP3A Substrates in Pregnancy: Predicting Changes in Midazolam and Nifedipine Pharmacokinetics.

Quinney SK, Mohamed AN, Hebert MF, Haas DM, Clark S, Umans JG, Caritis SN, Li L.

CPT Pharmacometrics Syst Pharmacol. 2012 Sep 26;1:e2. doi: 10.1038/psp.2012.5.

41.

A pilot study of the impact of genotype on nifedipine pharmacokinetics when used as a tocolytic.

Haas DM, Quinney SK, McCormick CL, Jones DR, Renbarger JL.

J Matern Fetal Neonatal Med. 2012 Apr;25(4):419-23. doi: 10.3109/14767058.2011.583700. Epub 2011 Jun 7.

PMID:
21644845
42.

Increased risk of vincristine neurotoxicity associated with low CYP3A5 expression genotype in children with acute lymphoblastic leukemia.

Egbelakin A, Ferguson MJ, MacGill EA, Lehmann AS, Topletz AR, Quinney SK, Li L, McCammack KC, Hall SD, Renbarger JL.

Pediatr Blood Cancer. 2011 Mar;56(3):361-7. doi: 10.1002/pbc.22845. Epub 2010 Nov 11.

43.

Independent influence of dietary protein on markers of kidney function and disease in obesity.

Friedman AN, Yu Z, Juliar BE, Nguyen JT, Strother M, Quinney SK, Li L, Inman M, Gomez G, Shihabi Z, Moe S.

Kidney Int. 2010 Oct;78(7):693-7. doi: 10.1038/ki.2010.184. Epub 2010 Jul 21.

44.

Measuring the glomerular filtration rate in obese individuals without overt kidney disease.

Friedman AN, Strother M, Quinney SK, Hall S, Perkins SM, Brizendine EJ, Inman M, Gomez G, Shihabi Z, Moe S, Li L.

Nephron Clin Pract. 2010;116(3):c224-34. doi: 10.1159/000317203. Epub 2010 Jul 2.

45.

Non-compartment model to compartment model pharmacokinetics transformation meta-analysis--a multivariate nonlinear mixed model.

Wang Z, Kim S, Quinney SK, Zhou J, Li L.

BMC Syst Biol. 2010 May 28;4 Suppl 1:S8. doi: 10.1186/1752-0509-4-S1-S8.

46.

Physiologically based pharmacokinetic model of mechanism-based inhibition of CYP3A by clarithromycin.

Quinney SK, Zhang X, Lucksiri A, Gorski JC, Li L, Hall SD.

Drug Metab Dispos. 2010 Feb;38(2):241-8. doi: 10.1124/dmd.109.028746. Epub 2009 Nov 2.

47.

Inhibition of CYP3A by erythromycin: in vitro-in vivo correlation in rats.

Zhang X, Galinsky RE, Kimura RE, Quinney SK, Jones DR, Hall SD.

Drug Metab Dispos. 2010 Jan;38(1):61-72. doi: 10.1124/dmd.109.028290.

PMID:
19797607
48.

Semiphysiologically based pharmacokinetic models for the inhibition of midazolam clearance by diltiazem and its major metabolite.

Zhang X, Quinney SK, Gorski JC, Jones DR, Hall SD.

Drug Metab Dispos. 2009 Aug;37(8):1587-97. doi: 10.1124/dmd.109.026658. Epub 2009 May 6.

PMID:
19420129
49.

Literature mining on pharmacokinetics numerical data: a feasibility study.

Wang Z, Kim S, Quinney SK, Guo Y, Hall SD, Rocha LM, Li L.

J Biomed Inform. 2009 Aug;42(4):726-35. doi: 10.1016/j.jbi.2009.03.010. Epub 2009 Apr 2.

50.

A new probabilistic rule for drug-dug interaction prediction.

Zhou J, Qin Z, Quinney SK, Kim S, Wang Z, Yu M, Chien JY, Lucksiri A, Hall SD, Li L.

J Pharmacokinet Pharmacodyn. 2009 Feb;36(1):1-18. doi: 10.1007/s10928-008-9107-3. Epub 2009 Jan 21.

Supplemental Content

Loading ...
Support Center